Erlocip 100 mg

Erlocip 100 mg (Erlotinib)

Active Ingredient (Generic Name): Erlotinib
Indication: Non-small cell lung cancer, Pancreatic cancer
Manufacturer: Cipla Limited
Packaging: 30 tablets in 1 bottle
Strength: 100mg
Delivery Time: 6 To 15 days
10% OFF: Use Code AM10 @ Checkout page

Erlocip 100 mg (Erlotinib) - 100 mg

100 mg Price Price/unit Quantity Add To Cart
30 Tablet/s $140 $4.67 /Tablet
60 Tablet/s $270 $4.5 /Tablet
90 Tablet/s $399 $4.43 /Tablet
Want to order in bulk / B2B price?Send Inquiry
Last Updated on
Medically Reviewed by
Dr. Zackefron

What Our Customer Says

Description

A brief overview of Erlocip 100 mg

Erlocip 100 mg tablet is an oral treatment for non-small cell lung cancer and pancreatic cancer. This medicine contains Erlotinib as the major active ingredient and belongs to the class of drugs called Kinase inhibitors.

It is prescribed among adults suffering from the types above of cancer when it has progressed to an advanced stage.

This medicine is mainly indicated among cancer patients when chemotherapy fails to stop the progression of the disease or is unable to manage pancreatic cancer along with gemcitabine.

The main function of Erlocip is to slow down the progression of cancer and improve the overall quality of life among cancer survivors.

Active ingredient: Erlotinib

Erlotinib is an FDA-approved active ingredient for the treatment and management of non-small cell lung cancer and pancreatic cancer. It classifies as a tyrosine kinase receptor inhibitor drug.

This active ingredient is mostly indicated with gefitinib (a targeted cancer therapy), primarily targeting the epidermal growth factor receptor (EGFR).

This key ingredient plays an important role in cancer’s cellular functions, such as differentiation (the differentiation of ECs into newly formulated capillaries), proliferation (uncontrolled growth), and angiogenesis (formation of new blood vessels), which the cancer cells utilize for abnormal growth and spread.

Cancers treated by Erlocip 100 mg

Non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is characterized by abnormal growth of cancer cells in the cell lining of the lungs. It is one of the most common types of cancer responsible for death worldwide. This type of cancer can affect smokers and non-smokers.

For improving the underlying symptoms of NSCLC, Erlocip 100 mg can be prescribed alone or in combination with other targeted cancer therapies. Although effective, this drug is regarded as toxic and needs to be handled carefully. The patient must stick to the advised treatment regimen and stay hydrated to reduce the risk of side effects.

Pancreatic cancer

This type of cancer affects the pancreas, the organ responsible for digesting the food we eat and performing the crucial function of metabolization blood sugar into insulin. Erlocip 100 mg is accountable for controlling pancreatic cancer and relieving associated symptoms such as decreased appetite and inexplicable weight loss. The main role of this drug is to inhibit the growth of chemicals in the body causing abnormal growth and spread of cancer cells. This way, it allows cancer patients to lead a longer and healthier life.

How should I take Erlocip 100 mg?

Your healthcare provider will suggest a proper treatment regimen as per the type and complexity level of cancer. Stick to the advised treatment plan for making the most out of the medication.

Typically, this medicine is used orally and once daily on an empty stomach only for faster absorption in the bloodstream. Try using it regularly at a fixed time to avail yourself of the desired health benefits. It should be taken without a meal or 2 hours after the meal (in case you forget to use on indicated times).

Swallow one whole Erlocip 100 mg tablet with a glass of water. This tablet should be consumed without breaking, chewing, or crushing.

Missed dose: The missed/skipped dose can be used immediately upon remembering. Do not double the dose to make up for missed dosage else it can trigger side effects.

Overdose: Avoid using this medicine beyond prescribed limits. If overdose accidentally, contact the healthcare provider or emergency helpline number immediately.

How does Erlocip 100 mg Work?

Erlocip 100 mg contains Erlotinib as the major component. It works by binding with the tyrosine kinase agents related to the epidermal growth factor receptor (EGFR) and blocks its activities. This further helps in inhibiting the abnormally rapid growth rate of cancer cells. The activities of epidermal growth factor receptor (EGFR) affect normal cells alongside impacting cancer cells. Resultantly, the growth and spread of the tumour decreases which increases the survival rates of the patient while causing the death of cancerous cells.

Gradually, cancerous cells are prevented from replication and worsening the underlying symptoms of non-small cell lung cancer and pancreatic cancer. Thus, the overall quality of life is elevated.

Proper storage instructions

  • Store Erlocip 100 tablets in a cool and dry place, away from direct sunlight & moisture.
  • Keep it out of reach and sight of children and pets.

Recommended dosage of Erlocip

  • Erlocip 100 mg – The standard dosage suggested as a part of initial-phase treatment for observing the response of the drug.
  • Erlocip 150 mg – This is a stronger version suggested when 100 mg is not enough for battling cancerous cells.

Potential Side Effects

Common side effects

  • Headache
  • Depression
  • Infection
  • Loss of appetite
  • Mouth infection
  • Difficulties in breathing
  • Cough
  • Fever
  • Fatigue
  • Aggressiveness
  • Nausea
  • Skin fissures
  • Itchy or dry skin
  • Indigestion
  • Stomach pain
  • Hair loss
  • Nasal bleeding
  • Inflammatory reactions
  • Acne
  • Increased sensitivity of skin, especially during sunlight exposure

Serious side effects

  • Loose or brittle nails
  • Changes in the outlook of eyelashes or eyebrows
  • Abnormal growth of hair over the body and face
  • Extremely painful soles or palms

When to seek medical help?

You’ll need medical attention immediately if any of the aforementioned side effects do not improve or the symptoms worsen causing discomfort.

Precautions and Contraindications

  • Do not use this medicine if allergic to Erlotinib.
  • Stay hydrated throughout the treatment period to minimize the risk of common side effects.
  • This medicine is not suitable for children below 18 years, pregnant & breastfeeding women, or patients with pre-existing major health issues.
  • Avoid drinking alcohol during the treatment period.
  • Do not drive right after the dosage due to the high risk of dizziness & drowsiness.
  • Don’t stop this medicine abruptly else the risk of withdrawal symptoms remains.

Conclusion

Erlocip 100 mg is a valuable treatment and a vital part of targeted therapy for pancreatic cancer and non-small cell lung cancer. When used properly, it can help in slowing down the progression of cancerous cells and improve overall wellness.

Order your Erlocip 100 mg online today.

FAQs

What is the use of Erlocip 100 mg tablets?

Erlocip 100 mg tablets are used for treating cancer in the pancreas and non-small cell lung cancer.

Which are the most common Erlocip 100 side effects?

Commonly, patients experience side effects of Erlocip 100 mg tablets like increased skin sensitivity when outdoors, nausea, headache, dizziness, hair loss, decreased appetite, etc. Seek medical help if any symptoms go beyond tolerable limits.

Is Erlocip 100 safe for children?

No, this cancer medicine is not safe for children below 18 years of age.

Can I use Erlocip 100 mg during pregnancy?

No, this medicine is restricted for use during pregnancy or breastfeeding. Tell your doctor if you are pregnant, planning to start a family, or breastfeeding already.

Where to buy Erlocip 100 mg?

Buy Erlocip 100 mg online from authorized pharmacies like arrowmeds.com where 100% quality-assured medicines are accessible at reasonable prices.

Reviews

There are no reviews yet.

Be the first to review “Erlocip 100 mg (Erlotinib)”

Your email address will not be published. Required fields are marked *